CD4 and neoplasm: Meanwhile, the reduced PD‐L1 expression, as inhibited by PD‐L1 siRNA, reactivated the T cells, encompassing both CD4+ T cells with the ability to recognize tumor cells and CD8+ T cells for subsequent tumor elimination (Figure 1E).